Form 4: Praxis Precision Medicines CFO Timothy Edwin Kelly Reports Stock Acquisition and Disposal

Chief Financial Officer Timothy Edwin Kelly reports acquiring and disposing of Praxis Precision Medicines, Inc. common stock on May 14, 2025.

Summary

• On May 14, 2025, Timothy Edwin Kelly, the Chief Financial Officer of Praxis Precision Medicines, Inc., acquired 249 shares of common stock at a price of $31.535 per share.
• Kelly also disposed of 24,279 shares of common stock on the same date.
• Following these transactions, Kelly directly owns an unspecified amount of Praxis Precision Medicines, Inc. common stock.
• The acquisition was made under the company's Employee Stock Purchase Plan and was exempt under Rule 16b-3(d) and Rule 16b-3(c).

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The acquisition through the employee stock purchase plan is mildly positive, but the disposal is neutral without further context.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan indicates Kelly's participation in the company's equity.

Negatives

• The disposal of 24,279 shares could be interpreted negatively, although the reason for disposal is not specified.

Risks

• The document does not provide enough information to assess the reasons behind the stock disposal, which could be due to various factors, including personal financial planning or diversification.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's important to consider this information in the context of overall company performance and industry trends.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The information provided is consistent with SEC regulations and reporting requirements.
• Similar filings can be compared across companies in the pharmaceutical industry to understand insider sentiment and trading patterns.

Stakeholder Impact

• Shareholders may be interested in insider trading activity as an indicator of management's confidence in the company.
• Employees participating in the Employee Stock Purchase Plan are directly impacted by the stock price and trading activity.

Key Dates

Keywords

Praxis Precision Medicines, Timothy Edwin Kelly, CFO, stock acquisition, stock disposal, Employee Stock Purchase Plan, Form 4, insider trading